NO993875L - Sammensetninger for behandling av ARDS eller IRDS inneholdende 3-(cyklopropylmetoksy)-N-(3,5-diklor-4-pyridinyl)-4-(difluormetoksy)benzamid og lungesurfaktant - Google Patents

Sammensetninger for behandling av ARDS eller IRDS inneholdende 3-(cyklopropylmetoksy)-N-(3,5-diklor-4-pyridinyl)-4-(difluormetoksy)benzamid og lungesurfaktant

Info

Publication number
NO993875L
NO993875L NO993875A NO993875A NO993875L NO 993875 L NO993875 L NO 993875L NO 993875 A NO993875 A NO 993875A NO 993875 A NO993875 A NO 993875A NO 993875 L NO993875 L NO 993875L
Authority
NO
Norway
Prior art keywords
irds
cyclopropylmethoxy
ards
treatment
difluoromethoxy
Prior art date
Application number
NO993875A
Other languages
English (en)
Other versions
NO323594B1 (no
NO993875D0 (no
Inventor
Paul-Georg Germann
Ulrich Kilian
Rolf Beume
Hermann Amschler
Uwe Krueger
Dietrich Hofner
Klaus Eistetter
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19705924A external-priority patent/DE19705924A1/de
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Publication of NO993875D0 publication Critical patent/NO993875D0/no
Publication of NO993875L publication Critical patent/NO993875L/no
Publication of NO323594B1 publication Critical patent/NO323594B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Detergent Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO993875A 1997-02-17 1999-08-11 Sammensetninger for behandling av IRDS eller ARDS omfattende N-(3,5-diklorpyrid-4-yl)-3-cyklopropylmetoksy-4-difluormetoksybenzamid og en lungesurfaktantsammensetning, samt deres anvendelse NO323594B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19705924A DE19705924A1 (de) 1997-02-17 1997-02-17 Neue Zusammensetzungen
EP97102639 1997-02-19
PCT/EP1998/000847 WO1998035683A1 (en) 1997-02-17 1998-02-14 Compositions for the treatment of ards or irds containing 3-(cyclopropylmethoxy)-n-(3,5-dichloro-4-pyridinyl)-4-(difluoromethoxy)benzamide and lung surfactant

Publications (3)

Publication Number Publication Date
NO993875D0 NO993875D0 (no) 1999-08-11
NO993875L true NO993875L (no) 1999-08-11
NO323594B1 NO323594B1 (no) 2007-06-11

Family

ID=26033977

Family Applications (1)

Application Number Title Priority Date Filing Date
NO993875A NO323594B1 (no) 1997-02-17 1999-08-11 Sammensetninger for behandling av IRDS eller ARDS omfattende N-(3,5-diklorpyrid-4-yl)-3-cyklopropylmetoksy-4-difluormetoksybenzamid og en lungesurfaktantsammensetning, samt deres anvendelse

Country Status (25)

Country Link
US (2) US6436970B1 (no)
EP (1) EP0977577B1 (no)
JP (1) JP4763104B2 (no)
KR (1) KR100640025B1 (no)
CN (1) CN1123345C (no)
AT (1) ATE336254T1 (no)
AU (1) AU734122B2 (no)
BR (1) BR9807399B1 (no)
CA (1) CA2276429C (no)
CZ (1) CZ293871B6 (no)
DE (1) DE69835594T2 (no)
DK (1) DK0977577T3 (no)
EA (1) EA001758B1 (no)
EE (1) EE04094B1 (no)
ES (1) ES2271990T3 (no)
HU (1) HU227520B1 (no)
IL (1) IL130658A (no)
NO (1) NO323594B1 (no)
NZ (1) NZ336569A (no)
PL (1) PL190775B1 (no)
PT (1) PT977577E (no)
SI (1) SI0977577T1 (no)
TR (1) TR199901772T2 (no)
UA (1) UA50808C2 (no)
WO (1) WO1998035683A1 (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR199901772T2 (no) * 1997-02-17 1999-09-21 Byk Gulden Lomberg Chemische Fabrik Gmbh
JP2001081031A (ja) * 1999-08-30 2001-03-27 Schering Ag 溶解性および経口吸収性を改善したベンズアミド誘導体含有製剤
WO2001019392A1 (en) * 1999-09-16 2001-03-22 Byk Gulden Lomberg Chemische Fabrik Gmbh Combination of c1-inh and lung surfactant for the treatment of respiratory disorders
DE19957898A1 (de) * 1999-12-01 2001-06-07 Byk Gulden Lomberg Chem Fab Neue Verwendung von Lungensurfactant
AU6196201A (en) * 2000-05-25 2001-12-03 Merck Frosst Canada Inc Fluoroalkoxy-substituted benzamide dichloropyridinyl n-oxide pde4 inhibitor
ATE303384T1 (de) 2001-05-24 2005-09-15 Merck Frosst Canada Inc 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren
US20030099601A1 (en) * 2001-11-27 2003-05-29 Gordon Marc S. Inhalation lung surfactant therapy
AU2002357168A1 (en) * 2001-12-12 2003-07-09 Penn State Research Foundation Surfactant prevention of lung complications from cancer chemotherapy
US20030170223A1 (en) * 2002-02-01 2003-09-11 Board Of Trustees Of Michigan State University Pulmonary vasodilator surfactant compositions and method of use
MY140561A (en) * 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
US6822114B1 (en) 2002-10-08 2004-11-23 Albemarle Corporation Process for production of fluoroalkoxy-substituted benzamides and their intermediates
DK1567139T3 (da) * 2002-11-27 2008-11-03 Nycomed Gmbh Hidtil ukendt synergistisk kombination der omfatter roflumilast og formoterol
DE60321954D1 (de) * 2002-11-27 2008-08-14 Nycomed Gmbh Synergistische zusammensetzung enthaltend roflumilast und (r,r)-formoterol
EA009985B1 (ru) 2003-03-10 2008-04-28 Никомед Гмбх Новый способ получения рофлумиласта
US7238664B2 (en) 2003-06-16 2007-07-03 Altana Pharma Ag Composition comprising a pulmonary surfactant and a PDE5 inhibitor for the treatment of lung diseases
CA2575513C (en) * 2004-08-06 2014-09-16 Altana Pharma Ag Composition comprising a pulmonary surfactant and a tnf-derived peptide
ES2421916T3 (es) * 2005-03-16 2013-09-06 Nycomed Gmbh Forma farmacéutica de sabor enmascarado que contiene roflumilast
AR064307A1 (es) * 2006-12-13 2009-03-25 Gilead Sciences Inc Monofosfatos utiles para el tratamiento de la inflamacion pulmonar y broncoconstriccion, formulaciones aerosolicas que los contienen, y metodo de preparacion.
WO2009055788A1 (en) * 2007-10-26 2009-04-30 Aeris Therapeutics, Inc. Pneumoreductive therapy and compositions useful therein
US20160199413A1 (en) * 2013-08-01 2016-07-14 Isletone Ab Mscs in the treatment of inflammatory pulmonary diseases
CN104800214A (zh) * 2014-01-27 2015-07-29 成都英诺新科技有限公司 一种罗氟司特吸入气雾剂复方及制备方法
RU2728821C1 (ru) * 2020-05-13 2020-07-31 Федеральное государственное бюджетное учреждение науки "Научный центр биомедицинских технологий Федерального медико-биологического агентства" (ФГБУН НЦБМТ ФМБА России) Способ лечения острого респираторного дистресс-синдрома даларгином и легочным сурфактантом

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4223040A (en) * 1974-11-26 1980-09-16 Carroll John M Lauric acid for the prevention and treatment of mycobacterial diseases
JPS5795920A (en) * 1980-12-04 1982-06-15 Teijin Ltd Remedy for respiratory disease
JPS5845299A (ja) * 1981-09-10 1983-03-16 東京田辺製薬株式会社 新規な表面活性物質、その製造法及びそれを含有する呼吸窮迫疾候群治療剤
GR82072B (no) * 1983-05-11 1984-12-13 Byk Gulden Lomberg Chem Fab
US4906476A (en) * 1988-12-14 1990-03-06 Liposome Technology, Inc. Novel liposome composition for sustained release of steroidal drugs in lungs
US5006343A (en) * 1988-12-29 1991-04-09 Benson Bradley J Pulmonary administration of pharmaceutically active substances
CZ290266B6 (cs) * 1993-07-02 2002-06-12 Byk Gulden Lomberg Chemische Fabrik Gmbh Substituované benzamidy, způsob jejich výroby a farmaceutické prostředky s jejich obsahem
US5856196A (en) * 1993-10-25 1999-01-05 Beth Israel Hospital Processes for quantitating phosphoglycerides in a lipid mixture and diagnostic uses therefor
GB9401460D0 (en) 1994-01-26 1994-03-23 Rhone Poulenc Rorer Ltd Compositions of matter
DE4434629C1 (de) * 1994-09-28 1996-06-27 Byk Gulden Lomberg Chem Fab Zusammensetzungen zur Behandlung von IRDS und ARDS
US5531219A (en) * 1994-11-04 1996-07-02 Alliance Pharmaceutical Corp. Use of liquid fluorocarbons to facilitate pulmonary drug delivery
US5698537A (en) * 1996-06-18 1997-12-16 Clarion Pharmaceuticals Inc. Method of lowering the viscosity of mucus
TR199901772T2 (no) * 1997-02-17 1999-09-21 Byk Gulden Lomberg Chemische Fabrik Gmbh
US6180142B1 (en) * 1998-08-21 2001-01-30 The Regents Of The University Of California Reduction of surfactant inactivation in pulmonary surfactant therapy
JP2003503830A (ja) * 1999-06-29 2003-01-28 エル−テック コーポレイション 化学的膜洗浄及び乾燥

Also Published As

Publication number Publication date
CA2276429C (en) 2007-06-19
UA50808C2 (uk) 2002-11-15
EA199900645A1 (ru) 2000-04-24
NO323594B1 (no) 2007-06-11
IL130658A0 (en) 2000-06-01
US6998410B2 (en) 2006-02-14
JP4763104B2 (ja) 2011-08-31
NZ336569A (en) 2001-04-27
IL130658A (en) 2004-07-25
PL190775B1 (pl) 2006-01-31
ATE336254T1 (de) 2006-09-15
EP0977577A1 (en) 2000-02-09
WO1998035683A1 (en) 1998-08-20
EE04094B1 (et) 2003-08-15
HUP0001043A2 (hu) 2000-09-28
SI0977577T1 (sl) 2007-02-28
EP0977577B1 (en) 2006-08-16
HU227520B1 (hu) 2011-07-28
DE69835594T2 (de) 2007-08-16
CN1248169A (zh) 2000-03-22
PL335134A1 (en) 2000-04-10
CZ293871B6 (cs) 2004-08-18
AU734122B2 (en) 2001-06-07
EE9900279A (et) 2000-02-15
US20020132835A1 (en) 2002-09-19
BR9807399A (pt) 2000-03-14
HUP0001043A3 (en) 2002-12-28
BR9807399B1 (pt) 2011-04-19
CN1123345C (zh) 2003-10-08
DK0977577T3 (da) 2006-12-18
NO993875D0 (no) 1999-08-11
ES2271990T3 (es) 2007-04-16
KR100640025B1 (ko) 2006-10-31
EA001758B1 (ru) 2001-08-27
TR199901772T2 (no) 1999-09-21
JP2001512452A (ja) 2001-08-21
PT977577E (pt) 2007-02-28
KR20000071112A (ko) 2000-11-25
CA2276429A1 (en) 1998-08-20
HK1026145A1 (en) 2000-12-08
DE69835594D1 (de) 2006-09-28
CZ291499A3 (cs) 2000-02-16
AU6497398A (en) 1998-09-08
US6436970B1 (en) 2002-08-20

Similar Documents

Publication Publication Date Title
NO993875D0 (no) Sammensetninger for behandling av ARDS eller IRDS inneholdende 3-(cyklopropylmetoksy)-N-(3,5-diklor-4-pyridinyl)-4-(difluormetoksy)benzamid og lungesurfaktant
NO20025355D0 (no) Farmasöytisk preparat som omfatter en faktor VIIa og en faktor XIII
TW329387B (en) Pharmaceutical composition for treating airway passage and lung diseases comprising mometasone furoate
CY1110379T1 (el) Συνθεση που περιλαμβανει φορμοτερολη και ενα γλυκοκορτικοστεροειδες
NO2008010I1 (no) Kombinasjon av efavirenz, emtricitabin og tenofovirdisoproks: 1 eller salter derav
DK0705099T3 (da) Anvendelse af modafinil til behandling af søvnapnø og åndedrætslidelser af central oprindelse
DK1363608T3 (da) Formuleringer omfattende ibuprofen og diphenhydramin og deres anvendelse til behandling af sovnforstyrrelser
DK0494405T3 (da) Anvendelse af thiazolidin-4-carboxylatderivater til behandling af lungesygdomme
DK1237549T3 (da) Lipoxin A4 og dets analoger til behandling af törre öjne
ID28119A (id) Pati yang dimodifikasi stabil-garam
ATE169225T1 (de) Anwendung von urodilatin bei lungen- und bronchialerkrankungen
ATE165827T1 (de) Herstellung von n-acetylneuraminsäure-derivaten
ATE514750T1 (de) Polyorganosiloxanzusammensetzung in emulsion und daraus hergestellte kosmetische formulierung
EP1403432A4 (en) PAPER FOR SMOKING ARTICLES REDUCING VISIBLE LATERAL SMOKE QUANTITY
BR9916489A (pt) Agente aromatizante tipo jogo
NO20032597D0 (no) Anvendelse av SARP-1 for behandlingen og/eller forebyggingen av skleroderma
BE870934Q (fr) Dispositif d'agrafage et agrafe, notamment pour cadres de bois
DK210081A (da) 1-(3,5-bistrifluormethylphenyl)-3-(4-tert. butylpiperidino)-prop-1-yn eller syreadditionssalte deraf dets fremstilling og anvendelse som rodenticid
DK284588D0 (da) Beta-lactam-forbindelser, deres fremstilling og anvendelse som laegemidler.
ATE311891T1 (de) Cytidin-diphosphocholin gegen diabetische neuropathie
TR200100906T2 (tr) Trombin inhibitörleri olarak benzamid türevleri
NO20000262D0 (no) Plasmider, deres konstruksjon og deres anvendelse i fremstilling av interleukin-4 og interleukin-4-muteiner
DE69129083D1 (de) Therapeutisches Mittel zur Vorbeugung und Behandlung des Atemnotsyndroms bei Erwachsenen
DK10187D0 (da) Methioninsubstituerede 1,4-dihydropuyridiner, deres fremstilling og anvendelse som laegemidler
ES2188189T3 (es) Composiciones que comprenden derivados de acido fenil-amino-tiofeno-acetico para el tratamiento del sindrome de angustia respiratoria aguda o de adultos (ards) y del sindrome de angustia respiratoria de niños (irds).

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: TAKEDA GMBH, DE

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: TAKEDA GMBH, DE

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: ASTRAZENECA AB, SE

MM1K Lapsed by not paying the annual fees